We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SLM:NASDAQSLM Corporation Analysis

Data as of 2026-09-01 - not real-time

$25.97

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind SLM Corporation is bullish at $25.97, with short-term averages leading the long-term ones. The last 30 days have gained 2.5%. Relative strength is 45.4 — neutral — and the MACD signal is bearish. Recent trading has carved out support near $25.78 and resistance around $28.27.
Valuation screens as undervalued: a P/E of 7.4 sits below the sector average of 16.9. Consensus targets land 9.9% above where the shares trade now. Revenue is growing at 8.1% on a 43.6% profit margin. The 1.97% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 31.3%, a beta of 0.97 and a maximum drawdown of 41.0%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 6/10.

Top Market Events

SLM Corp SLM reports a rise in loan originations and strategic partnerships, despite facing pressure from increased net...Morningstar%2c Inc.1monSallie Mae Declares Dividends on Preferred Stock Series B and Common StockSallie Mae Nasdaq: SLM...Investing5monSLM Share News TodayInvesting.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 24.55
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 7.4 versus sector average of 16.9
  • Trading above the 200-day average of 24.55

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 7.4 versus sector average of 16.9
  • Analyst targets imply +9.9% versus the current price
  • Profit margin of 43.6% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth8.10%
Profit Margin43.63%
P/E Ratio7.4
ROE30.33%
ROA2.53%
Debt/Equity236.16
Op. Cash Flow$-324595008
Industry P/E16.9

Technical Analysis

TrendBullish
RSI45.4
Support$25.78
Resistance$28.27
MA 20$27.01
MA 50$25.88
MA 200$24.55
MACDBearish
VolumeDecreasing
Fear & Greed Index94.71

Valuation

Target Price$28.55
Upside/Downside9.92%
GradeUndervalued
TypeBlend
Dividend Yield1.97%

Risk Assessment

Beta0.97
Volatility31.25%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.